Europe, Middle East, And Africa Point-Of-Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Cancer Marker, Coagulation Testing, Infectious Disease), By End Use (Clinics, Home), By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Glucose Testing
4.3.1. Glucose Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Hb1Ac Testing
4.4.1. Hb1Ac Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Coagulation Testing
4.4.2.1. Coagulation Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Fertility/Pregnancy
4.4.3.1. Fertility/Pregnancy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Infectious Disease
4.4.4.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.1. HIV POC
4.4.4.1.1.1. HIV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.2. Clostridium Difficile POC
4.4.4.1.2.1. Clostridium Difficile POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.3. HBV POC
4.4.4.1.3.1. HBV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.4. Pneumonia or Streptococcus Associated Infections
4.4.4.1.4.1. Pneumonia or Streptococcus Associated Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.5. Respiratory Syncytial Virus (RSV) POC
4.4.4.1.5.1. Respiratory Syncytial Virus (RSV) POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.6. HPV POC
4.4.4.1.6.1. HPV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.7. Influenza/Flu POC
4.4.4.1.7.1. Influenza/Flu POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.8. HCV POC
4.4.4.1.8.1. HCV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.9. MRSA POC
4.4.4.1.9.1. MRSA POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.10. TB and Drug-resistant TB POC
4.4.4.1.10.1. TB and Drug-resistant TB POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.11. HSV POC
4.4.4.1.11.1. HSV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.12. COVID-19
4.4.4.1.12.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.1.13. Other Infectious Diseases
4.4.4.1.13.1. Other Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Cardiac Markers
4.4.5.1. Cardiac Markers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Thyroid Stimulating Hormone
4.4.6.1. Thyroid Stimulating Hormone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.7. Hematology
4.4.7.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.8. Primary Care Systems
4.4.8.1. Primary Care Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.9. Decentralized Clinical Chemistry
4.4.9.1. Decentralized Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.10. Feces
4.4.10.1. Feces Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.11. Lipid Testing
4.4.11.1. Lipid Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.12. Cancer Marker
4.4.12.1. Cancer Marker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.13. Blood Gas/Electrolytes
4.4.13.1. Blood Gas/Electrolytes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.14. Ambulatory Chemistry
4.4.14.1. Ambulatory Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.15. Drug of Abuse (DOA) Testing
4.4.15.1. Drug of Abuse (DOA) Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.16. Autoimmune Diseases
4.4.16.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.17. Urinalysis/Nephrology
4.4.17.1. Urinalysis/Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
5.3. Clinics
5.3.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.1. Pharmacy & Retail Clinics
5.3.1.1.1. Pharmacy & Retail Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2. Physician Office
5.3.1.2.1. Physician Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.3. Urgent Care Clinics
5.3.1.3.1. Urgent Care Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.4. Non-practice Clinics
5.3.1.4.1. Non-practice Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Home
5.5.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Assisted Living Healthcare Facilities
5.6.1. Assisted Living Healthcare Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Laboratory
5.7.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Europe, Middle East, and Africa Point-Of-Care Diagnostics Market Share, By Region, 2023 & 2030, USD Million
6.2. Europe
6.2.1. Europe Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.K.
6.2.2.1. U.K. Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Germany
6.2.3.1. Germany Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. France
6.2.4.1. France Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.5. Italy
6.2.5.1. Italy Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.6. Spain
6.2.6.1. Spain Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.7. Denmark
6.2.7.1. Denmark Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.8. Sweden
6.2.8.1. Sweden Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.9. Norway
6.2.9.1. Norway Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Middle East and Africa
6.3.1. Middle East and Africa Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. South Africa
6.3.2.1. South Africa Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Saudi Arabia
6.3.3.1. Saudi Arabia Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. UAE
6.3.4.1. UAE Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Kuwait
6.3.5.1. Kuwait Point-Of-Care Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. F. Hoffmann-La Roche Ltd
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. QIAGEN
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Danaher Corporation
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. BD (Becton Dickinson)
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. BIOMÉRIEUX
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Abbott
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Siemens Healthcare Private Limited
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Werfen
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Nova Biomedical
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Trividia Health, Inc.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives